Latest News
This is the comment period for the Proposed Rulemaking Notice, Title 27, Proposed Repeal of Sections 25607.30 and 25607.31.
| Program: Proposition 65
Extension of the comment period on the proposal to adopt a No Significant Risk Level (NSRL) of 180 micrograms per day for malathion
| Program: Proposition 65
2017 Children's Health Symposium "Environmental Health and Children" - location, agenda, directions and additional information.
| Program: Risk Assessment
February 2, 2017 community meeting in Los Angeles to discuss the use of Cap-and-Trade proceeds to fund projects in disadvantaged and low-income communities to implement Senate Bill 535.
| Program: CalEnviroScreen
February 6, 2017 community meeting in Oakland to discuss the use of Cap-and-Trade proceeds to fund projects in disadvantaged and low-income communities to implement Senate Bill 535.
| Program: CalEnviroScreen
February 7, 2017 webinar to discuss the use of Cap-and-Trade proceeds to fund projects in disadvantaged and low-income communities to implement Senate Bill 535.
| Program: CalEnviroScreen
February 1, 2017 community meeting in Fresno to discuss the use of Cap-and-Trade proceeds to fund projects in disadvantaged and low-income communities to implement Senate Bill 535.
| Program: CalEnviroScreen
Pertuzumab and Vismodegib Listed Effective January 27, 2017 as Known to the State of California to Cause Reproductive Toxicity via the Formally Required to be Labeled or Identified (FR) mechanism.
| Program: Proposition 65
(CalEnviroScreen 3.0: Spanish)
OEHHA a nombre de la CalEPA, anuncia la disponibilidad del Instrumento de Evaluación de la Salud Ambiental de las Comunidades de California: CalEnviroScreen 3.0.
| Program: CalEnviroScreen
CalEnviroScreen 3.0:
El Instrumento de Evaluación de Salud Ambiental de las Comunidades de California Versión 3.0 (CalEnviroScreen 3.0).
| Program: CalEnviroScreen